| Company Name: |
ShangHai Biochempartner Co.,Ltd
|
| Tel: |
177-54423994 17754423994 |
| Email: |
2853530910@QQ.com |
| Products Intro: |
Product Name:Gedivumab
CAS:1807954-17-1
Purity:95% Package:100ug;500ug;1mg
|
| Company Name: |
Guangzhou Hongyuan Chemical Co.,Ltd
|
| Tel: |
15817493340 |
| Email: |
981810490@qq.com |
| Products Intro: |
Product Name:Gedivumab
CAS:1807954-17-1
Purity:95% Package:1mg;1g;100g
|
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18108604356 |
| Email: |
products@biolabreagent.com |
| Products Intro: |
Product Name:Research Grade Gedivumab (DVV03804)
CAS:1807954-17-1
Purity:PAGE:>95% Package:100ug;1mg
|
|
| | Gedivumab Basic information |
| Product Name: | Gedivumab | | Synonyms: | Gedivumab;Research Grade Gedivumab (DVV03804);Research Grade Gedivumab | | CAS: | 1807954-17-1 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Gedivumab Structure]() |
| | Gedivumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Gedivumab Usage And Synthesis |
| Uses | Gedivumab (MHAA4549A; RG7745) is a human monoclonal antibody that targets influenza A virus (IAV) with high specificity and binds to the highly conserved stem region of the IAV haemagglutinin protein, thereby preventing haemagglutinin maturation and blocking haemagglutinin-mediated membrane fusion in the intranucleosome. Gedivumab can be used in IAV infection disease studies[1]. | | References | [1] Jeremy J Lim, et al. Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers. Antimicrob Agents Chemother. 2016 Aug 22;60(9):5437-44. DOI:10.1128/AAC.00607-16 |
| | Gedivumab Preparation Products And Raw materials |
|